Gagneux-Brunon, A., Mariat, C., Delanaye, P., Cystatin C in HIV-infected patients: promising but not yet ready for prime time. Nephrol Dial Transplant 27 (2012), 1305–1313.
Inker, L.A., Wyatt, C., Creamer, R., Hellinger, J., Hotta, M., Leppo, M., et al. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr 61 (2012), 302–309.
Gagneux-Brunon, A., Delanaye, P., Maillard, N., Fresard, A., Basset, T., Alamartine, E., et al. Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort. AIDS 27 (2013), 1573–1581.
Lucas, G.M., Ross, M.J., Stock, P.G., Shlipak, M.G., Wyatt, C.M., Gupta, S.K., et al. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV medicine association of the Infectious diseases society of America. Clin Infect Dis, 2014, 617.
Okparavero, A.A., Tighiouart, H., Krishnasami, Z., Wyatt, C.M., Graham, H., Hellinger, J., et al. Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients. Antivir Ther 18 (2013), 793–802.
Koteff, J., Borland, J., Chen, S., Song, I., Peppercorn, A., Koshiba, T., et al. A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects. Br J Clin Pharmacol 75 (2013), 990–996.
Maggi, P., Montinaro, V., Mussini, C., Di Biagio, A., Bellagamba, R., Bonfanti, P., et al. Novel antiretroviral drugs and renal function monitoring of HIV patients. AIDS Rev 16 (2014), 144–151.
German, P., Liu, H.C., Szwarcberg, J., Hepner, M., Andrews, J., Kearney, B.P., et al. Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function. J Acquir Immune Defic Syndr 1999 61 (2012), 32–40.
Bröchner-Mortensen, J., Haahr, J., Christoffersen, J., A simple method for accurate assessment of the glomerular filtration rate in children. Scand J Clin Lab Invest 33 (1974), 140–143.
Du Bois, D., Du Bois, E.F., A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med XVII (1916), 863–871.
Cockcroft, D.W., Gault, M.H., Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976), 31–41.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. Modification of diet in renal disease study grup. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461–70.
Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y.L., Castro, A.F. 3rd., Feldman, H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150 (2009), 604–612.
Delanaye, P., Mariat, C., Maillard, N., Krzesinski, J.-M., Cavalier, E., Are the creatinine-based equations accurate to estimate glomerular filtration rate in african american populations?. Clin J Am Soc Nephrol 6 (2011), 906–912.
Golik, M.V., Lawrence, K.R., Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: cockcroft-gault and modification of diet in renal disease. Pharmacotherapy 28 (2008), 1125–1132.
Delanaye, P., Krzesinski, J.M., Indexing of renal function parameters by body surface area: intelligence or folly?. Nephron Clin Pract 119 (2011), c289–c292.
Ryom, L., Mocroft, A., Kirk, O., Ross, M., Reiss, P., Fux, C.A., et al. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. AIDS 28 (2014), 187–199.
Matzke, G.R., Aronoff, G.R., Atkinson, A.J. Jr., Bennett, W.M., Decker, B.S., Eckardt, K.U., et al. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int 80 (2011), 1122–1137.
Bhasin, B., Lau, B., Atta, M.G., Fine, D.M., Estrella, M.M., Schwartz, G.J., et al. HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin C. Plos One, 8, 2013, e82028.
Gutiérrez, F., Fulladosa, X., Barril, G., Domingo, P., Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management. AIDS Rev 16 (2014), 199–212.
Rodríguez-Nóvoa, S., Labarga, P., Soriano, V., Egan, D., Albalater, M., Morello, J., et al. Predictors of kidney tubular dysfunction in hiv-infected patients treated with tenofovir: a pharmacogenetic study. Clin Infect Dis 48 (2009), e108–e116.
Baxi, S.M., Greenblatt, R.M., Bacchetti, P., Scherzer, R., Minkoff, H., Huang, Y., et al. Common clinical conditions – age, low BMI, ritonavir use, mild renal impairment – affect tenofovir pharmacokinetics in a large cohort of HIV-infected women. AIDS 28 (2014), 59–66.
Choi, A.I., Rodriguez, R.A., Bacchetti, P., Volberding, P.A., Havlir, D., Bertenthal, D., et al. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis 45 (2007), 1633–1639.
